Five with MIT ties elected to National Academy of Medicine for 2025
Professors Facundo Batista and Dina Katabi, along with three additional MIT alumni, are honored for their outstanding professional achievement and commitment to service.
MIT researchers develop AI tool to improve flu vaccine strain selection
VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.
How AI could speed the development of RNA vaccines and other RNA therapies
MIT engineers used a machine-learning model to design nanoparticles that can deliver RNA to cells more efficiently.
Supercharged vaccine could offer strong protection with just one dose
By delivering an HIV vaccine candidate along with two adjuvants, researchers showed they could generate many more HIV-targeting B cells in mice.
Study in India shows several tactics together boost vaccination against deadly diseases
One combination of methods led to a 44 percent increase in child immunizations.
Particles carrying multiple vaccine doses could reduce the need for follow-up shots
MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.
Biologists identify targets for new pancreatic cancer treatments
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
Is this the new playbook for curing rare childhood diseases?
When his son received a devastating diagnosis, Fernando Goldsztein MBA ’03 founded an initiative to help him and others.
A new vaccine approach could help combat future coronavirus pandemics
The nanoparticle-based vaccine shows promise against many variants of SARS-CoV-2, as well as related sarbecoviruses that could jump to humans.
A blueprint for better cancer immunotherapies
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
A new approach to modeling complex biological systems
MIT engineers’ new model could help researchers glean insights from genomic data and other huge datasets.
A two-dose schedule could make HIV vaccines more effective
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.
A new way to reprogram immune cells and direct them toward anti-tumor immunity
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.
Researchers study differences in attitudes toward Covid-19 vaccines between women and men in Africa
While women and men self-reported similar vaccination rates, unvaccinated women had less intention to get vaccinated than men.
MIT scientists use a new type of nanoparticle to make vaccines more powerful
Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose.